---
$id: https://graph.org.ai/products/commodity/51241245
$type: Product
source: UNSPSC
code: "51241245"
title: "Lithium succinate"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lithium succinate

**UNSPSC Code**: 51241245
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C4H4O4.2LI, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MD64P82Y28. European Medicines Agency schedules lithium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14381MIG. The term lithium succinate is a U.S. FDA designation. As of Q4 2014, LITHIUM SUCCINATE remains the US FDA Preferred Term for this commodity. SMILES: OC(=O)CCC(=O)O.[Li].

